Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Forum for Injection Technique and Therapy Expert Recommendations, India: The Indian Recommendations for Best Practice in Insulin Injection Technique, 2017.

Tandon N, Kalra S, Balhara YPS, Baruah MP, Chadha M, Chandalia HB, Prasanna Kumar KM, Madhu SV, Mithal A, Sahay R, Shukla R, Sundaram A, Unnikrishnan AG, Saboo B, Gupta V, Chowdhury S, Kesavadev J, Wangnoo SK.

Indian J Endocrinol Metab. 2017 Jul-Aug;21(4):600-617. doi: 10.4103/ijem.IJEM_97_17. Review.

2.
3.

TREATMENT OF TYPE 2 DIABETES WITH BIPHASIC INSULIN ANALOGUES.

Rizvi AA.

Eur Med J Diabetes. 2016;4(1):74-83. Epub 2016 Oct 27.

4.

Efficacy and safety of biphasic insulin aspart and biphasic insulin lispro mix in patients with type 2 diabetes: A review of the literature.

Kumar A.

Indian J Endocrinol Metab. 2016 May-Jun;20(3):288-99. doi: 10.4103/2230-8210.179993. Review.

5.

Clinical experience of switching from biphasic human insulin to biphasic insulin aspart 30 in Indian patients with type 2 diabetes in the A1chieve study.

Das AK, Kalra S, Akhtar S, Shetty R, Kumar A.

Indian J Endocrinol Metab. 2015 Jan-Feb;19(1):110-5. doi: 10.4103/2230-8210.131759.

6.

Role of premixed insulin analogues in the treatment of patients with type 2 diabetes mellitus: a narrative review.

Elizarova S, Galstyan GR, Wolffenbuttel BH.

J Diabetes. 2014 Mar;6(2):100-10. doi: 10.1111/1753-0407.12096. Epub 2014 Jan 21. Review.

7.

Intensification of insulin therapy for type 2 diabetic patients in primary care: basal-bolus regimen versus premix insulin analogs: when and for whom?

Mosenzon O, Raz I.

Diabetes Care. 2013 Aug;36 Suppl 2:S212-8. doi: 10.2337/dcS13-2007. Review. No abstract available.

8.

Diabetes: glycaemic control in type 2 (drug treatments).

Gorter KJ, van de Laar FA, Janssen PG, Houweling ST, Rutten GE.

BMJ Clin Evid. 2012 Oct 11;2012. pii: 0609. Review.

9.

Safety and effectiveness of biphasic insulin aspart 30 in different age-groups: a1chieve sub-analysis.

Khamseh ME, Haddad J, Yang W, Zilov A, Bech OM, Hasan MI.

Diabetes Ther. 2013 Dec;4(2):347-61. doi: 10.1007/s13300-013-0033-z. Epub 2013 Jul 17.

10.

Rapid-Acting Insulin Analogues for the Treatment of Diabetes Mellitus: Meta-analyses of Clinical Outcomes.

Canadian Agency for Drugs and Technologies in Health (CADTH).

CADTH Technol Overv. 2010;1(1):e0110. Epub 2010 Mar 1. No abstract available.

11.

Ten years of experience with biphasic insulin aspart 30: from drug development to the latest clinical findings.

Liebl A, Prusty V, Valensi P, Kawamori R, Christiansen JS, Palmer AJ, Balschmidt P, Ligthelm R, Mohan V.

Drugs. 2012 Jul 30;72(11):1495-520. doi: 10.2165/11635490-000000000-00000. Review.

12.

Uncovering undetected hypoglycemic events.

Unger J.

Diabetes Metab Syndr Obes. 2012;5:57-74. doi: 10.2147/DMSO.S29367. Epub 2012 Mar 8.

13.
14.

Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial.

Lund SS, Tarnow L, Frandsen M, Nielsen BB, Hansen BV, Pedersen O, Parving HH, Vaag AA.

BMJ. 2009 Nov 9;339:b4324. doi: 10.1136/bmj.b4324.

15.

Improved Glycaemic Control with Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients Failing Oral Antidiabetic Drugs: PRESENT Study Results.

G├╝ler S, Sharma SK, Almustafa M, Kim CH, Azar S, Danciulescu R, Shestakova M, Khutsoane D, Bech OM.

Arch Drug Inf. 2009 Jun;2(2):23-33.

16.

Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis.

Singh SR, Ahmad F, Lal A, Yu C, Bai Z, Bennett H.

CMAJ. 2009 Feb 17;180(4):385-97. doi: 10.1503/cmaj.081041.

17.

Initiating or switching to biphasic insulin aspart 30/70 therapy in subjects with type 2 diabetes mellitus. An observational study.

Breum L, Almdal T, Eiken P, Lund P, Christiansen E; Danish BIAsp Study Group.

Rev Diabet Stud. 2008 Fall;5(3):154-62. doi: 10.1900/RDS.2008.5.154. Epub 2008 Nov 10.

18.

Systematic review: comparative effectiveness and safety of premixed insulin analogues in type 2 diabetes.

Qayyum R, Bolen S, Maruthur N, Feldman L, Wilson LM, Marinopoulos SS, Ranasinghe P, Amer M, Bass EB.

Ann Intern Med. 2008 Oct 21;149(8):549-59. Epub 2008 Sep 15. Review.

19.

Review of biphasic insulin aspart in the treatment of type 1 and 2 diabetes.

Raja-Khan N, Warehime SS, Gabbay RA.

Vasc Health Risk Manag. 2007;3(6):919-35. Review.

Supplemental Content

Support Center